PMID: 8455815Jan 1, 1993Paper

Trends in place preference conditioning with a cross-indexed bibliography; 1957-1991

Neuroscience and Biobehavioral Reviews
M D Schechter, D J Calcagnetti

Abstract

The purpose of this work is to present a perspective of the conditioned place preference (CPP) test by offering an overview of the empirical research from 1957-1991. The intent is not to extensively analyze the controversies inherent to any behavioral technique but rather to present a survey of research using a descriptive statistics approach to explore topical issues. The objectives of this work are three-fold: (a) to provide an exhaustive bibliography of the CPP literature including articles, journal abstracts, book chapters and critical reviews; (b) to provide a cross-index of identified key words/drugs tested; and (c) to give an overview of selected procedural issues underlying CPP testing.

References

Aug 1, 1979·Pharmacology, Biochemistry, and Behavior·R J Katz, G Gormezano
Nov 1, 1979·Behavioral and Neural Biology·C L Cunningham
Jan 1, 1992·Progress in Neuro-psychopharmacology & Biological Psychiatry·D J Calcagnetti, M D Schechter
Jan 1, 1992·Annual Review of Psychology·N M White, P M Milner
Apr 1, 1992·Physiology & Behavior·D J Calcagnetti, M D Schechter
Nov 19, 1991·European Journal of Pharmacology·T SuzukiH Nagase
Jan 1, 1991·Pharmacology, Biochemistry, and Behavior·M D Schechter
Mar 1, 1991·Pharmacology, Biochemistry, and Behavior·M D Schechter
Oct 1, 1991·Pharmacology, Biochemistry, and Behavior·D J Calcagnetti, M D Schechter
Dec 1, 1991·Pharmacology, Biochemistry, and Behavior·D V GauvinF A Holloway
Jan 1, 1991·Psychopharmacology·K A TrujilloL Stein
May 1, 1991·Pharmacology, Biochemistry, and Behavior·R de BeunN E van de Poll
Jan 1, 1991·Life Sciences·F V Abbott, K B Franklin
Jan 1, 1991·Psychopharmacology·A Ettenberg, T D Geist
Jan 1, 1991·Journal of Addictive Diseases·T W Seale, J M Carney
Mar 1, 1991·Pharmacology, Biochemistry, and Behavior·N T BrockwellR J Beninger
Mar 1, 1991·Pharmacology, Biochemistry, and Behavior·C L Duvauchelle, A Ettenberg
Oct 1, 1990·Pharmacology, Biochemistry, and Behavior·P Schnur, J Morrell
Dec 1, 1990·Pharmacology, Biochemistry, and Behavior·G MeisenbergS A Lorens
Sep 1, 1990·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·G ColomboG L Gessa
Sep 1, 1990·Pharmacology, Biochemistry, and Behavior·M T BardoB A Mattingly
Feb 1, 1990·Pharmacology, Biochemistry, and Behavior·M A Bozarth
Jan 1, 1990·Psychopharmacology·J L NeisewanderM T Bardo

❮ Previous
Next ❯

Citations

Dec 31, 1997·Developmental Psychobiology·D D MaceC K Akins
Feb 19, 2005·Psychopharmacology·Julie A BlendyCaryn Lerman
Jul 31, 2007·Psychopharmacology·Hai-feng ZhaiLin Lu
Aug 1, 1994·European Journal of Pharmacology·M D Schechter, S M Meechan
Jun 6, 1995·European Journal of Pharmacology·M D SchechterJ B Schechter
Jan 1, 1994·Life Sciences·D J Calcagnetti, M D Schechter
Dec 1, 1994·Pharmacology, Biochemistry, and Behavior·T C DurazzoF A Holloway
Jun 1, 1995·Pharmacology, Biochemistry, and Behavior·M D Schechter
Jan 1, 1996·Pharmacology, Biochemistry, and Behavior·W GongJ B Justice
Aug 1, 1996·Pharmacology, Biochemistry, and Behavior·R De BeunJ De Vry
Jan 1, 1995·Neuroscience and Biobehavioral Reviews·M T BardoM J Harris
Jan 1, 1996·Neuroscience and Biobehavioral Reviews·A Tomie
May 1, 1994·Progress in Neuro-psychopharmacology & Biological Psychiatry·S M Meehan, M D Schechter
Sep 1, 1994·Progress in Neuro-psychopharmacology & Biological Psychiatry·D J Calcagnetti, M D Schechter
Jan 1, 1995·Brain Research Bulletin·A M MamoonB Hoskins
Mar 17, 2004·Neuroscience and Biobehavioral Reviews·Aaron Ettenberg
Jun 7, 2005·Pharmacology, Biochemistry, and Behavior·Eliot L Gardner
May 24, 2005·Pharmacology, Biochemistry, and Behavior·Gregory D BusseAnthony L Riley
Dec 23, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Gregory D BusseAnthony L Riley
Dec 31, 2002·Chemistry and Physics of Lipids·Eliot L Gardner
Aug 19, 2003·European Journal of Pharmacology·Jolanta KotlinskaJerzy Silberring
Apr 4, 1998·European Journal of Pharmacology·W M Meil, M D Schechter
Jan 1, 1997·Life Sciences·C V Borlongan, S Watanabe
Jun 6, 2000·Pharmacology, Biochemistry, and Behavior·C BelzungR Hen
Mar 20, 2002·Pharmacology, Biochemistry, and Behavior·Bow Tong LettGillian Flynn
Jan 25, 2003·Pharmacology, Biochemistry, and Behavior·Suzette M EvansRichard W Foltin
Apr 2, 2003·Pharmacology, Biochemistry, and Behavior·Tangui MauricePascal Romieu
Sep 23, 1997·Pharmacology, Biochemistry, and Behavior·R GaginY Shavit
Jun 4, 1998·Pharmacology, Biochemistry, and Behavior·J KatajamäkiL Ahtee
Jun 4, 1998·Pharmacology, Biochemistry, and Behavior·C K RandallM T Bardo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.